Oxford Biomedica (OXB) Stock Chart & Stock Price History GBX 426.50 +2.00 (+0.47%) (As of 12/20/2024 12:31 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades Oxford Biomedica Stock Price Performance 5 Day Performance+0.71%1 Month Performance+3.39%3 Month Performance+19.47%6 Month Performance+36.70%Year-To-Date Performance+93.86%1 Year Performance+116.50% Receive OXB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. Email Address ⭕ [URGENT] Buy Alert just triggered (Ad)My absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> OXB Stock Chart for Sunday, December, 22, 2024 OXB Chart by TradingView Oxford Biomedica Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024GBX 424.50GBX 426.50+0.47%GBX 426.50GBX 412423,996 shs£449.36 million12/19/2024GBX 425.50GBX 424.50-0.24%GBX 427GBX 406.50200,475 shs£447.25 million12/18/2024GBX 421GBX 425.50+1.07%GBX 427GBX 419.50143,161 shs£448.31 million12/17/2024GBX 423.50GBX 421-0.59%GBX 426GBX 42078,478 shs£443.57 million12/16/2024GBX 423.50GBX 423.50GBX 429GBX 406.50191,682 shs£446.20 million12/13/2024GBX 430GBX 423.50-1.51%GBX 433.43GBX 411.50193,471 shs£446.20 million Get the Latest News and Ratings for OXB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024GBX 430GBX 430GBX 433GBX 429.50223,530 shs£453.05 million12/11/2024GBX 429.50GBX 430+0.12%GBX 433.44GBX 42892,890 shs£453.05 million12/10/2024GBX 427GBX 429.50+0.59%GBX 432.50GBX 425165,278 shs£452.52 million12/09/2024GBX 426.50GBX 427+0.12%GBX 437GBX 422.50207,981 shs£449.89 million12/06/2024GBX 425GBX 426.50+0.35%GBX 433GBX 42568,059 shs£449.36 million12/05/2024GBX 427.50GBX 425-0.58%GBX 428GBX 414.50127,070 shs£447.78 million12/04/2024GBX 427.50GBX 427.50GBX 431GBX 409305,323 shs£450.41 million12/03/2024GBX 425.50GBX 427.50+0.47%GBX 438.13GBX 42589,330 shs£450.41 million12/02/2024GBX 428.50GBX 425.50-0.70%GBX 430GBX 420130,606 shs£448.31 million11/29/2024GBX 430GBX 428.50-0.35%GBX 430GBX 42563,250 shs£451.47 million11/28/2024GBX 425GBX 430+1.18%GBX 430GBX 419.5064,200 shs£453.05 million11/27/2024GBX 422.61GBX 425+0.57%GBX 428GBX 418.50188,312 shs£447.78 million11/26/2024GBX 424.50GBX 422.61-0.45%GBX 428.84GBX 42143,447 shs£445.26 million11/25/2024GBX 420GBX 424.50+1.07%GBX 430GBX 411.83171,698 shs£447.25 million11/22/2024GBX 412.50GBX 420+1.82%GBX 422GBX 398.8056,655 shs£442.51 million11/21/2024GBX 412.50GBX 412.50GBX 416.28GBX 400.50126,410 shs£434.61 million11/20/2024GBX 412.50GBX 412.50GBX 418GBX 410329,368 shs£434.61 million Related Companies Oxford Nanopore Technologies Stock Price Chart Genus Stock Price Chart PureTech Health Stock Price Chart Bioventix Stock Price Chart Faron Pharmaceuticals Oy Stock Price Chart Avacta Group Stock Price Chart 4basebio Stock Price Chart hVIVO Stock Price Chart Scancell Stock Price Chart Futura Medical Stock Price Chart Receive OXB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. This page (LON:OXB) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.